HSF1 and neurodegenerative disease: Given the potential therapeutic role of elevated protein chaperone levels in diseases of protein conformation and the coordinated expression of Hsps via the action of human HSF1, small molecule activation of human HSF1 is likely to be a promising avenue for therapeutic intervention in neurodegenerative disease.